DeepMed Research

ICAHN School of Medicine At Mount Sinai

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1963-01-01

Employees: 5K

Market Cap: -

Website: http://www.mssm.edu

Clinical Trials

Renal Allograft Fibrosis Study

Conditions: Renal Allograft Fibrosis

First Posted Date: 2021-09-27

Last Posted Date: 2024-07-01

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 280

Registration Number: NCT05058170

Locations: 🇺🇸
Weill Cornell Medicine, New York, New York, United States
🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

An Oral GnRH Antagonist to Treat Mild Autonomous Cortisol Excess (MACE) Due to Adrenal Adenomas in Postmenopausal Women

Phase 4

Terminated

Conditions: Mild Autonomous Cortisol Excess

Interventions: Drug: Elagolix

First Posted Date: 2021-09-09

Last Posted Date: 2025-03-18

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 4

Registration Number: NCT05038878

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Neurocognition After Perturbed Sleep

Not Applicable

Completed

Conditions: Schizophrenia

Interventions: Behavioral: Overnight polysomnography examinations

First Posted Date: 2021-09-02

Last Posted Date: 2025-03-04

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 28

Registration Number: NCT05032963

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

The Personal Patient Profile Decision Support for Patients With Bladder Cancer

Not Applicable

Completed

Conditions: Bladder Cancer

Interventions: Behavioral: P3BC

First Posted Date: 2021-09-02

Last Posted Date: 2024-12-31

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 24

Registration Number: NCT05033067

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
🇺🇸
University of Washington, Seattle, Washington, United States

Investigation of the Pharmacokinetic Profile of CBD

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Cannabidiol

First Posted Date: 2021-08-26

Last Posted Date: 2025-02-26

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 24

Registration Number: NCT05023070

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease Patients

Not Applicable

Recruiting

Conditions: Mild Cognitive Impairment

Interventions: Device: Circadian-Effective Light
Device: Placebo Rhythmic Light
Device: Placebo Light
Device: Rhythmic Light

First Posted Date: 2021-08-23

Last Posted Date: 2024-08-15

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 120

Registration Number: NCT05016219

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
🇺🇸
Light and Health Research Center, Menands, New York, United States

Rhythmic Light Therapy for Alzheimer's Disease Patients

Not Applicable

Completed

Conditions: Mild Cognitive Impairment

Interventions: Device: Tailored Rhythmic Lighting Intervention
Device: Placebo Rhythmic Lighting Intervention

First Posted Date: 2021-08-20

Last Posted Date: 2024-12-03

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 52

Registration Number: NCT05015478

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
🇺🇸
Light and Health Research Center, Menands, New York, United States

Vestibular Caloric Stimulation and the Modulation of Pain in Fibromyalgia

Not Applicable

Completed

Conditions: Fibromyalgia

Interventions: Procedure: Vestibular Caloric Stimulation

First Posted Date: 2021-08-13

Last Posted Date: 2021-08-19

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 21

Registration Number: NCT05004194

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Telehealth Referral to Improve Outcomes

Not Applicable

Suspended

Conditions: Hypertension

Interventions: Device: blood pressure cuff PLUS tablet
Other: Telehealth Consult

First Posted Date: 2021-08-11

Last Posted Date: 2023-05-01

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 48

Registration Number: NCT05000970

Locations: 🇺🇸
Mount Sinai Hospital Center Emergency Dept, New York, New York, United States

Dupilumab in the Treatment of Keloids

Phase 4

Active, not recruiting

Conditions: Keloid

Interventions: Drug: Dupilumab
Drug: Placebo

First Posted Date: 2021-08-03

Last Posted Date: 2024-10-02

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 44

Registration Number: NCT04988022

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy